22
Sep 2026
New research has found that mothers with poor sleep quality in late pregnancy had babies with lower weight in the first 6 months of life, but higher weight after age 1-2 years.
22
Sep 2026
New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different.
22
Sep 2026
Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer.
22
Sep 2026
An international coalition of vascular access surgeons, nephrologists, researchers and industry partners today launched the Fight Fibrin Sheath (FFS) campaign, a clinician-led action group working collaboratively to advance research, education and innovation relating to fibrin sheath formation, and to improve vascular access outcomes for dialysis patients worldwide.
22
Sep 2026
Photothermal Spectroscopy Corp., a leader in submicron infrared spectroscopy and chemical imaging, today announced the launch of the mIRage®-HSi, a high-speed laser-scanning Optical Photothermal Infrared (O-PTIR) microscope delivering more than 30 times faster IR imaging while maintaining sub-500 nm spatial resolution.
22
Sep 2026
Photothermal Spectroscopy Corp. today announced the release of stRAMos™, a next-generation Raman microscope based on photothermal detection of Stimulated Raman scattering, or SRS.
22
Sep 2026
The pharmaceutical and biopharmaceutical industries increasingly require rapid, accurate, and high-resolution analytical tools to characterize complex materials, ensure product quality, and accelerate innovation.
22
Sep 2026
With Western Australia projected to record the nation's fastest growth in dementia cases, a new Curtin University-led resource aims to help people protect their brain health and reduce their risk.
22
Sep 2026
Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious brain and eye diseases, today announced the establishment of a dedicated Alzheimer's Disease Scientific Advisory Board (SAB).
22
Sep 2026
A large ABCD study of 10,838 children found that prenatal cannabis exposure was associated with small differences in resting-state brain connectivity, higher behavioral and emotional problem scores, and lower performance on several cognitive measures in late childhood. PCE-related connectivity patterns partly overlapped with those linked to psychopathology and cognition, although the cross-sectional observational design cannot establish causality or mediation.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
